Cite

HARVARD Citation

    Yonker, L. et al. (2022). Zonulin Antagonist, Larazotide (AT1001), As an Adjuvant Treatment for Multisystem Inflammatory Syndrome in Children: A Case Series. Critical care explorations. pp. e0641-. [Online]. 
  
Back to record